Trial NCT01822756

View at ClinicalTrials.gov 
Org. Study IDs: INCB 18424-144

Last trial update was posted on 2018-02-12

MeSH Interventions

Gemcitabine Paclitaxel

MeSH Conditions


Other Conditions

Pancreatic Cancer Solid Tumors

Stopping Reasons

Dose escalation ended after Cohort B1, RUX 10 mg BID - GCSF in October 2014.

Limitations And Caveats

In October 2014, further enrollment of additional study cohorts was stopped; Part 2 of the study wasn't conducted. Pharmacokinetic and Pharmacodynamics analyses weren't performed due to early termination. Maximum tolerated dose (MTD) was not reached.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID